Form 4: Alignment Healthcare President Sells Shares for Tax

Alignment Healthcare's President, Dawn Christine Maroney, sold shares to cover tax withholding obligations related to performance share unit vesting, not as a discretionary trade.

Summary

• Dawn Christine Maroney, President of Alignment Healthcare, Inc., sold a total of 282,070 shares of common stock.
• The sales occurred on December 29, 2025.
• The first sale involved 266,603 shares at a weighted-average price of $18.7056 per share, with prices ranging from $18.23 to $19.225.
• The second sale involved 15,467 shares at a weighted-average price of $19.3818 per share, with prices ranging from $19.23 to $19.51.
• These transactions were non-discretionary, executed solely to cover tax withholding obligations associated with the vesting of performance share units.
• Following these transactions, Maroney beneficially owns 1,385,167 shares of Alignment Healthcare common stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a non-discretionary sale to cover tax obligations from vested equity, which is a routine event for executives and not indicative of a change in confidence or company performance.

Positives

• The transaction was non-discretionary, indicating it was not a signal of lack of confidence in the company by the officer.
• The sale was pre-planned under Rule 10b5-1(c), demonstrating adherence to insider trading regulations.

Negatives

• A significant number of shares (282,070) were sold, which could be perceived negatively by some investors, despite the stated reason.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4.

Management Comments

• Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of performance share units. This transaction does not represent a discretionary trade by the reporting person.

Industry Context

This Form 4 filing is a routine disclosure of an insider stock transaction. It does not provide broader industry trends or competitive analysis. Such transactions are common for executives receiving equity compensation.

Related Party Transactions

• This filing details a direct transaction by an officer of the company, which is a type of related party transaction, but no other specific related party dealings are disclosed beyond the officer's compensation-related sale.

Stakeholder Impact

• Shareholders: The sale of shares by an executive, even for tax purposes, slightly reduces the executive's direct ownership stake. However, given the non-discretionary nature, it is unlikely to signal a negative outlook.
• Employees: No direct impact on employees is indicated.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated.

Key Dates

Recommendation

The filing details a routine, non-discretionary sale of shares by an executive to cover tax obligations from vested equity. This type of transaction is common and does not typically signal a change in the company's fundamentals or the executive's confidence. Therefore, it does not warrant a change in investment recommendation based solely on this filing. Investors should hold their position and consider broader company performance and market conditions.

Keywords

Alignment Healthcare, ALHC, Form 4, Insider Trading, Stock Sale, Tax Withholding, Performance Share Units, Executive Compensation, Dawn Christine Maroney, Rule 10b5-1